Technology Insight: Applications of MRI for the evaluation of benign disease of the pancreas

Nature Clinical Practice Gastroenterology and Hepatology

Volumn 4, Issue 3, 2007, Pages 148-159

  Kinney, Timothy P ^a,c   Punjabi, Gopal ^b,c   Freeman, Martin ^a,c  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c HENNEPIN COUNTY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SECRETIN; DIAGNOSTIC AGENT; GASTROINTESTINAL AGENT;

ACUTE PANCREATITIS; CHRONIC PANCREATITIS; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; ENDOSCOPIC THERAPY; HUMAN; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; MEDICAL DECISION MAKING; NON INVASIVE PROCEDURE; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS DISEASE; PANCREAS DIVISUM; PANCREAS DUCT; PANCREAS DUCT STENOSIS; PANCREAS FUNCTION; PATIENT DECISION MAKING; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS; TREATMENT PLANNING; VATER PAPILLA STENOSIS; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; PATHOPHYSIOLOGY;

CHOLANGIOPANCREATOGRAPHY, MAGNETIC RESONANCE; GASTROINTESTINAL AGENTS; HUMANS; MAGNETIC RESONANCE IMAGING; PANCREATIC DISEASES; SECRETIN; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY;

EID: 33847746648     PISSN: 17434378     EISSN: 17434386     Source Type: Journal    
DOI: 10.1038/ncpgasthep0760     Document Type: Review

References (74)

1. Whitcomb DC (2006) Clinical practice. Acute pancreatitis. N Engl J Med 354:2142-2150
2. Turner MA (2002) The role of US and CT in pancreatitis. Gastrointest Endosc 56 (Suppl 6): S241-S245
3. Walsh TN et al. (1992) Minimal change chronic pancreatitis. Gut 33:1566-1571
4. Forsmark CE (2000) The diagnosis of chronic pancreatitis. Gastrointest Endosc 52: 293-298
5. Freeman ML (2003) Understanding risk factors and avoiding complications with endoscopic retrograde cholangiopancreatography. Curr Gastroenterol Rep 5: 145-153
6. Ducreux M et al. (1992) Management of malignant hilar biliary obstruction by endoscopy. Results and prognostic factors. Dig Dis Sci 37: 778-783
7. Freeman ML and Overby C (2003) Selective MRCP and CT-targeted drainage of malignant hilar biliary obstruction with self-expanding metallic stents. Gastrointest Endosc 58: 41-49
8. Feitoza AB and Baron TH (2002) Endoscopy and ERCP in the setting of previous upper GI tract surgery. Part II: Postsurgical anatomy with alteration of the pancreaticobiliary tree. Gastrointest Endosc 55: 75-79
9. Feitoza AB and Baron TH (2001) Endoscopy and ERCP in the setting of previous upper GI tract surgery. Part I: Reconstruction without alteration of pancreaticobiliary anatomy. Gastrointest Endosc 54: 743-749
10. Matos C et al. (1997) Pancreatic duct: Morphologic and functional evaluation with dynamic MR pancreatography after secretin stimulation. Radiology 203: 435-441
11. Punwani S et al. (2003) Non-invasive quantification of pancreatic exocrine function using secretin-stimulated MRCP. Eur Radiol 13:273-276
12. Mariani A et al. (2003) Secretin MRCP and endoscopic pancreatic manometry in the evaluation of sphincter of Oddi function: A comparative pilot study in patients with idiopathic recurrent pancreatitis. Gastrointest Endosc 58: 847-852
13. Bali MA et al. (2005) Quantification of pancreatic exocrine function with secretin-enhanced magnetic resonance cholangiopancreatography: normal values and short-term effects of pancreatic duct drainage procedures in chronic pancreatitis. Initial results. Eur Radiol 15: 2110-2121
14. Merkle EM and Baillie J (2006) Exocrine pancreatic function: Evaluation with MR imaging before and after secretin stimulation. Am J Gastroenterol 101: 137-138
15. Schneider AR et al. (2006) Does secretin-stimulated MRCP predict exocrine pancreatic insufficiency? A comparison with noninvasive exocrine pancreatic function tests. J Clin Gastroenterol 40: 851-855
16. Pereira SP et al. (2006) Prospective comparison of secretin-stimulated MRCP with manometry in the diagnosis of sphincter of Oddi dysfunction types II and III. Gut [doi:10.1136/gut.2006.099267]
17. Matos C et al. (2006) Magnetic resonance imaging in the detection of pancreatitis and pancreatic neoplasms. Best Pract Res Clin Gastroenterol 20: 157-178
18. Sodickson A et al. (2006) Three-dimensional fast-recovery fast spin-echo MRCP: Comparison with two-dimensional single-shot fast spin-echo techniques. Radiology 238: 549-559
19. Matos C et al. (1999) Secretin-enhanced MR pancreatography. Semin Ultrasound CT MR 20: 340-351
20. Bali M et al. (2005) Quantification of pancreatic exocrine function with secretin-enhanced magnetic resonance cholangiopancreatography: Normal values and short-term effects of pancreatic duct drainage procedures in chronic pancreatitis. Eur Radiol 15: 2110-2121
21. Punwani S et al. (2003) Non-invasive quantification of pancreatic exocrine function using secretin-stimulated MRCP. Eur Radiol 13: 273-276
22. Schneider A et al. (2006) Does secretin-stimulated MRCP predict exocrine pancreatic insufficiency? A comparison with noninvasive exocrine pancreatic function tests. J Clin Gastroenterol 40: 851-855
23. Norton ID and Clain JE (2000) The role of transabdominal ultrasonography, helical computed tomography, and magnetic resonance cholangiopancreatography in diagnosis and management of pancreatic disease. Curr Gastroenterol Rep 2: 120-124
24. Gandolfi L et al. (2003) The role of ultrasound in biliary and pancreatic diseases. Eur J Ultrasound 16: 141-159
25. Balthazar E (2002) Acute pancreatitis: Assessment of severity with clinical and CT evaluation. Radiology 223: 603-613
26. Mortele K et al. (2004) Peripancreatic vascular abnormalities complicating acute pancreatitis: Contrast-enhanced helical CT findings. Eur J Radiol 52: 67-72
27. Morcos SK et al. (1999) Contrast-media-induced nephrotoxicity: A consensus report. Contrast Media Safety Committee, European Society of Urogenital Radiology (ESUR). Eur Radiol 9: 1602-1613
28. Maher MM et al. (2004) Application of rational practice and technical advances for optimizing radiation dose for chest CT. J Thorac Imaging 19: 16-23
29. Soto J et al. (2005) Pancreas divisum: Depiction with multi-detector row CT. Radiology 235: 503-508
30. Fukukura Y et al. (2003) Intraductal papillary mucinous tumors of the pancreas. Comparison of helical CT and MR imaging. Acta Radiol 44: 464-471
31. Brown A et al. (2002) Can fluid resuscitation prevent pancreatic necrosis in severe acute pancreatitis? Pancreatology 2: 104-107
32. Romagnuolo J et al. (2003) Magnetic resonance cholangiopancreatography: a meta-analysis of test performance in suspected biliary disease. Ann Intern Med 139: 547-557
33. Zidi SH et al. (1999) Use of magnetic resonance cholangiography in the diagnosis ofcholedocholithiasis: Prospective comparison with a reference imaging method. Gut 44: 118-122
34. Kinney TP and Freeman ML (2005) The role of endoscopic retrograde cholangiopancreatography and endoscopic ultrasound in diagnosis and treatment of acute pancreatitis. Minerva Gastroenterol Dietol 51: 265-288
35. Ayub K et al. (2004) Endoscopic retrograde cholangiopancreatography in gallstone-associated acute pancreatitis. The Cochrane Database of Systematic Reviews, Issue 4, Art. No CD003630
36. Arvanitakis M et al. (2004) Computed tomography and magnetic resonance imaging in the assessment of acute pancreatitis. Gastroenterology 126: 715-723
37. Gillams AR et al. (2006) Diagnosis of duct disruption and assessment of pancreatic leak with dynamic secretin-stimulated MR cholangiopancreatography. AJR Am J Roentgenol 186: 499-506
38. Steer ML et al. (1995) Chronic pancreatitis. N Engl J Med 332: 1482-1490
39. Banks PA (1991) Management of pancreatic pain. Pancreas 6 (Suppl 1): S52-S59
40. Ahmed SA et al. (2006) Chronic pancreatitis: Recent advances and ongoing challenges. Curr Probl Surg 43: 127-238
41. Nath DS et al. (2004) Total pancreatectomy with intraportal auto-islet transplantation using a temporarily exteriorized omental vein. J Am Coll Surg 199: 994-995
42. Catalano MF et al. (1998) Prospective evaluation of endoscopic ultrasonography, endoscopic retrograde pancreatography, and secretin test in the diagnosis of chronic pancreatitis. Gastrointest Endosc 48: 11-17
43. Sahai AV (2002) EUS and chronic pancreatitis. Gastrointest Endosc 56 (Suppl 4): S76-S81
44. Cappeliez O et al. (2000) Chronic pancreatitis: Evaluation of pancreatic exocrine function with MR pancreatography after secretin stimulation. Radiology 215: 358-364
45. Sica GT et al. (2002) Magnetic resonance imaging in patients with pancreatitis: Evaluation of signal intensity and enhancement changes. J Magn Reson Imaging 15: 275-284
46. Coenegrachts K et al. (2004) Dynamic contrast-enhanced MRI of the pancreas: Initial results in healthy volunteers and patients with chronic pancreatitis. J Magn Reson Imaging 20: 990-997
47. Zhang XM et al. (2003) Suspected early or mild chronic pancreatitis: enhancement patterns on gadolinium chelate dynamic MRI. Magnetic resonance imaging. J Magn Reson Imaging 17: 86-94
48. Guelrud M (1996) The incidence of pancreas divisum in children. Gastrointest Endosc 43: 83-84
49. Khalid A and Slivka A (2001) Pancreas divisum. Curr Treat Options Gastroenterol 4: 389-399
50. Matos C et al. (2001) Pancreas divisum: Evaluation with secretin-enhanced magnetic resonance cholangio pancreatography. Gastrointest Endosc 53: 728-733
51. Manfredi R et al. (2000) Pancreas divisum and "santorinicele": diagnosis with dynamic MR cholangiopancreatography with secretin stimulation. Radiology 217: 403-408
52. Coyle WJ et al. (2002) Evaluation of unexplained acute and acute recurrent pancreatitis using endoscopic retrograde cholangiopancreatography, sphincter of Oddi manometry and endoscopic ultrasound. Endoscopy 34: 617-623
53. Testoni PA (2000) Idiopathic recurrent pancreatitis: Long-term results after ERCP, endoscopic sphincterotomy, or ursodeoxycholic acid treatment. Am J Gastroenterol 95: 1702-1707
54. Freeman ML et al. (1996) Complications of endoscopic biliary sphincterotomy. N Engl J Med 335: 909-918
55. Khalid A et al. (2003) Secretin-stimulated magnetic resonance pancreaticogram to assess pancreatic duct outflow obstruction in evaluation of idiopathic acute recurrent pancreatitis: A pilot study. Dig Dis Sci 48: 1475-1481
56. Russell RT and Sharp KW (2005) Mucinous cystadenoma of the pancreas associated with acute pancreatitis and concurrent pancreatic pseudocyst. Am Surg 71: 292-297
57. Nocente R et al. (2001) An apparent idiopathic case of relapsing acute pancreatitis. Hepatogastroenterology 48: 572-573
58. Mosca S et al. (2001) Hepatobiliary and pancreatic: A woman with recurrent idiopathic acute pancreatitis. Intraductal papillary mucinous tumor of the pancreas. J Gastroenterol Hepatol 16: 1070-1075
59. Tikhomirov V et al. (2000) A pancreatic intraductal papillary mucinous tumor causing recurrent acute pancreatitis at the onset of menstrual periods. J Clin Gastroenterol 31: 172-174
60. Trevino JG et al. (2006) Intraductal papillary mucinous neoplasms of the pancreas. Curr Treat Options Gastroenterol 9: 385-390
61. Serikawa M et al. (2006) Management of intraductal papillary mucinous neoplasm of the pancreas: Treatment strategy based on morphologic classification. J Clin Gastroenterol 40: 856-862
62. Prasad SR et al. (2003) Intraductal papillary mucinous tumors of the pancreas. Abdom Imaging 28: 357-365
63. Sugiyama M et al. (2003) Magnetic resonance cholangiopancreatography for postoperative follow-up of intraductal papillary mucinous tumors of the pancreas. Am J Surg 185: 251-255
64. Hartmann D et al. (2004) ERCP and MRCP in the differentiation of pancreatic tumors. Dig Dis 22: 18-25
65. Sahani DV et al. (2006) Intraductal papillary mucinous neoplasm of pancreas: Multi-detector row CT with 2D curved reformations - correlation with MRCP. Radiology 238: 560-569
66. Sahani D et al. (2002) Cystic pancreatic neoplasms evaluation by CT and magnetic resonance cholangiopa ncreatography. Gastrointest Endosc Clin North Am 12: 657-672
67. McGrath K and Slivka A (2005) Diagnosis and management of intraductal papillary mucinous neoplasia. Nat Clin Pract Gastroenterol Hepatol 2: 316-322
68. Glasbrenner B et al. (2002) Modern diagnostics of chronic pancreatitis. Eur J Gastroenterol Hepatol 14: 935-941
69. Chowdhury RS and Forsmark CE (2003) Review article: Pancreatic function testing. Aliment Pharmacol Ther 17: 733-750
70. Keim V et al. (2003) Clinical value of a new fecal elastase test for detection of chronic pancreatitis. Clin Lab 49: 209-215
71. Heverhagen JT et al. (2002) Magnetic resonance hydrometry: Non-invasive quantification of the exocrine pancreatic function. Rofo 174: 291-296
72. Heverhagen JT et al. (2001) MR hydrometry to assess exocrine function of the pancreas: Initial results of noninvasive quantification of secretion. Radiology 218: 61-67
73. Czako L et al. (2001) Evaluation of pancreatic exocrine function by secretin-enhanced magnetic resonance cholangiopancreatography. Pancreas 23: 323-328
74. Erturk SM et al. (2006) Diffusion-weighted MR imaging in the evaluation of pancreatic exocrine function before and after secretin stimulation. Am J Gastroenterol 101: 133-136